Fold Holdings, Inc. Warrant is a biotechnology enterprise dedicated to pioneering therapeutic solutions for rare genetic disorders. The company is advancing a strong pipeline of proprietary drug candidates through clinical development, highlighting its focus on addressing critical unmet medical needs in the healthcare landscape. With a strategic emphasis on innovation, Fold Holdings represents a compelling opportunity for institutional investors seeking growth and diversification within the biopharmaceutical industry, particularly as it aims to transform treatment paradigms for underserved…